Skip to the page

Data / Form D filings / Duke Street Bio Ltd

Duke Street Bio Ltd: Form D filings

Duke Street Bio Ltd, a biotechnology company in London, United Kingdom, filed 5 Form D notices with the SEC between 2020 and 2026. The latest, on June 11, 2026, reports $4.1 million sold of a $4.1 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2 DUKE STREET, London, United Kingdom, W1U 3
Phone
44-203-8908710
Industry
Biotechnology
Entity type
Other
Incorporated in
United Kingdom
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1823388

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 11, 2026New notice$4,136,978$4,136,9782May 15, 2026sec.gov
Jan 17, 2024New notice$2,528,201$2,528,2011Jan 3, 2024sec.gov
May 25, 2022New notice$2,440,238$2,440,2381May 16, 2022sec.gov
Jun 7, 2021New noticeIndefinite$141,6501May 24, 2021sec.gov
Sep 9, 2020New notice$26,595$26,5951Sep 3, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter TrillDirector
Phillip CowleyDirector
Alan WiseDirector
Donnie ChristianDirector
Harvey McGrathDirector
Barry McGuinnessExecutive Officer

Every Form D from the week of Jun 8, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Duke Street Bio Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.